Radiolabeled Antibodies for Imaging and Targeted Therapy
- 1 April 2023
- book chapter
- Published by Springer Nature
- p. 533-575
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate CancerFrontiers in Oncology, 2013
- 124I-huA33 Antibody PET of Colorectal CancerJournal of Nuclear Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid LeukemiaClinical Cancer Research, 2010
- Allogeneic hematopoietic cell transplantation after conditioning with 131I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndromeBlood, 2009
- Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out viewNuclear Medicine and Biology, 2007
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- 177Lu‐DOTA‐HuJ591: A new radiolabeled monoclonal antibody (MAb) for targeted therapy of prostate cancerJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- The Hallmarks of CancerCell, 2000
- Linking radiometals to proteins with bifunctional chelating agentsThe Protein Journal, 1984